A Phase II Study on the Effect of Taurisolo ® Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study.
Stefano Sanduzzi ZamparelliLudovica CapitelliNicola CoppolaClaudia VendittoCiro SantoroGiuseppe AnnunziataDario BruzzeseNunzia CuomoGentile IvanMarialuisa BocchinoAlessandro Sanduzzi ZamparelliPublished in: Cells (2022)
aerosol formulation. We could argue that this treatment could act as an add-on therapy in the treatment of COVID-19 patients, owing to both its anti-inflammatory and antioxidant effects. Further controlled trials are needed, which may be of interest to evaluate the compound's efficacy.